London Biotechnology Show 2026

EUROPE’S FLAGSHIP B2B EXPOSITION FOR MEDICAL BIOTECHNOLOGY, GENE THERAPY & LIFE SCIENCES INNOVATION ARRIVES IN LONDON!

Organized by Valiant Business Media, the landmark edition of the London Biotechnology Show (LBS 2026) brings together global pharmaceutical leaders, biotech startups, clinical researchers, CROs/CDMOs, medtech innovators, venture capitalists, and life sciences policymakers across the global healthcare ecosystem!

Hosted at the world-class ExCeL London, this mega 2-day trade exposition and multi-stream international conference serves as a high-impact business platform for red biotechnology, precision medicine, biomanufacturing scale-up, and next-generation therapeutics. Designed to accelerate drug discovery, facilitate regulatory compliance, and unlock global investment, the showcase connects over 150 leading exhibitors and 50+ keynote experts directly with targeted healthcare decision-makers and enterprise buyers!

Dates: Wednesday, November 18 – Thursday, November 19, 2026

Hours: 09:00 AM – 05:00 PM (Daily)

Venue: ExCeL London (Hall N22, Entrance N11), Royal Victoria Dock, 1 Western Gateway, London E16 1XL, United Kingdom

Target Audience: Chief Scientific Officers, Heads of R&D, Clinical Research Directors, Biotech Founders & Scale-up Executives, Biomanufacturing Engineers, Venture Capital & Private Equity Investors, Regulatory Affairs Managers, and Life Sciences Procurement Heads.

Key Exhibition Pavilions & Core Sector Domains:

Biopharmaceuticals, Vaccines & Advanced Therapeutics: Biologics, mRNA platforms, viral vector development, monoclonal antibodies, and next-generation immunotherapies.

Gene & Cell Therapy & Genomic Editing: CRISPR technologies, CAR-T cell therapies, gene delivery systems, and advanced cell engineering solutions.

Bioinformatics, AI & Computational Biology: AI-driven drug discovery platforms, predictive molecular modeling, biological data analytics, and cloud lab infrastructure.

Diagnostics, Precision Medicine & Biomarkers: Companion diagnostics, liquid biopsy technologies, molecular diagnostics, and personalized medicine frameworks.

Biomanufacturing, CDMO & Process Innovation: Continuous bioprocessing, bioreactor systems, downstream processing, single-use technologies, and cleanroom automation.

LabTech, Automation & Clinical Research (CRO): Automated liquid handlers, high-throughput screening tools, laboratory consumables, and clinical trial management platforms.

B2B Matchmaking, Global Biotech Awards & Expert Keynotes: Engage in pre-scheduled 1-on-1 buyer-seller networking, attend expert-led conference sessions on commercializing lab research, inspect live bioprocessing and lab automation demonstrations, evaluate investment deals, and accelerate your life sciences pipeline!

Advance your biotech capabilities, discover groundbreaking medical technologies live, and connect with global life sciences pioneers at ExCeL London!

#LondonBiotechnologyShow #LBS2026 #ExCeLLondon #Biotechnology #Biopharma #GeneTherapy #CellTherapy #PrecisionMedicine #Bioinformatics #LifeSciences #Biomanufacturing #MedTech #ClinicalResearch #B2BIndustrialExpo #HealthTech Innovation

Trade Shows

Biopharmaceuticals, Vaccines & Advanced Therapeutics

Gene & Cell Therapy & Genomic Editing

Bioinformatics, AI & Computational Biology

Diagnostics, Precision Medicine & Biomarkers
Biomanufacturing, CDMO & Process Innovation
What are the dates and location?
The event takes place from 18–19 November 2026 at ExCeL London, inside Hall N22 (Entrance N11).
What is the primary focus of LBS26?
The show focuses strictly on the "red biotechnology" value chain. This encompasses medical and pharmaceutical applications including biologics, drug discovery, cell/gene therapy, diagnostics, and vaccine development from R&D through to commercial clinical delivery.

Leave a reply

Event Detail

November 18, 2026 9:00 AM
November 19, 2026 5:00 PM
ExCeL London (Hall N22, Entrance N11), Royal Victoria Dock, 1 Western Gateway, London E16 1XL, United Kingdom

Event Sponsers